Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIB Prostate Cancer”

241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 241 results

Not applicableStudy completedNCT00416390
What this trial is testing

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Who this might be right for
Nonmalignant NeoplasmProstate Cancer
University of Illinois at Chicago 120
Testing effectiveness (Phase 2)Ended earlyNCT01928485
What this trial is testing

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Sanjay Gupta PhD 6
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Early research (Phase 1)Study completedNCT00030277
What this trial is testing

High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Focus Surgery 20
Testing effectiveness (Phase 2)Study completedNCT01882985
What this trial is testing

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of California, Irvine 14
Testing effectiveness (Phase 2)Study completedNCT00450411
What this trial is testing

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 100
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Large-scale testing (Phase 3)Study completedNCT00769548
What this trial is testing

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,322
Testing effectiveness (Phase 2)Active Not RecruitingNCT03412396
What this trial is testing

Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8
M.D. Anderson Cancer Center 45
Early research (Phase 1)Study completedNCT02048150
What this trial is testing

Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage IIB Prostate CancerStage III Prostate Cancer+1 more
City of Hope Medical Center 7
Large-scale testing (Phase 3)Study completedNCT06601205
What this trial is testing

Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.

Who this might be right for
Prostate CancerProstatic Intraepithelial Neoplasia
Ente Ospedaliero Ospedali Galliera 125
Large-scale testing (Phase 3)Study completedNCT00055731
What this trial is testing

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Who this might be right for
Prostate Cancer
UNICANCER 413
Very early researchLooking for participantsNCT05852041
What this trial is testing

RhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+1 more
Northwestern University 40
Large-scale testing (Phase 3)Study completedNCT00765479
What this trial is testing

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of Illinois at Chicago 284
Early research (Phase 1)Study completedNCT02119858
What this trial is testing

Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery

Who this might be right for
Stage IIA Prostate CancerStage IIB Prostate Cancer
City of Hope Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Not applicableStudy completedNCT00003903
What this trial is testing

Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer

Who this might be right for
OsteoporosisProstate Cancer
University of Rochester 150
Load More Results